What happened, in summary

Lucy found a breast lump at 23, months after learning that she carried a germline BRCA1 mutation. Several clinicians thought the area felt like fibrous tissue, but because of her inherited risk she continued with imaging and biopsy. Three days after her 24th birthday, she was diagnosed with grade 3 triple-negative breast cancer. A biopsy also found cancer in a small number of axillary lymph nodes. Her oncologist described the stage as between late stage 2 and early stage 3.

Before treatment, Lucy froze eggs. She then entered a clinical trial and received carboplatin every 3 weeks with weekly paclitaxel, alongside intermittent olaparib tablets, for 4 cycles. This was followed by 3 cycles of EC chemotherapy. Low platelets caused a treatment delay and required a platelet transfusion, but midway imaging could no longer identify the tumor beyond its marker.

After chemotherapy, Lucy chose a bilateral mastectomy. Her right side received an implant, while reconstruction on the cancer-affected left side was delayed because she also needed radiation. Pathology results on June 17 showed no remaining cancer.

At the time of the interview, Lucy described herself as cancer-free. She continued reviews with her oncologist every 3–4 months and was preparing to discuss delayed reconstruction. Her experience reinforced the importance of checking persistent changes even when a person is young and a lump does not feel typical.